يعرض 1 - 10 نتائج من 806 نتيجة بحث عن '"gastric tumor"', وقت الاستعلام: 0.98s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
    20240208 Comparison of clinical efficacy between laparoscopic total gastrectomy and proximal gastrectomy in the treatment of adenocarcinoma of esophagogastric junction http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20240208 10.13429/j.cnki.cjcr.2024.02.008 DAI Dezhu, SHI Jin, SONG Xudong, DING Fan, TAO Guoquan Department of Gastrointestinal Surgery, The Affiliated Huai ‘an No.1 People ‘s Hospital of Nanjing Medical University, Huai ‘an,Jiangsu 223300, China Objective To compare the advantages and disadvantages of two different resection margins by observing the clinical efficacy of laparoscopic total gastrectomy (TG) and proximal gastrectomy(PG) for radical resection of adenocarcinoma of esophagogastric junction (AEJ). Methods A total of 90 patients with AEJ who were treated by Huai ‘an No.1 People ‘s Hospital from January 2020 to December 2021 were retrospectively reviewed. Patients were divided into PG group ( n=43) and TG group ( n=47) according to the surgical resection range. The general data, surgery related statistical indicators of the two groups were compared. Results The TG group had a longer operation time than the PG group, with significantly more intraoperative blood loss and a greater number of intraoperatively cleared lymph nodes than the PG group (P<0.05). There was no significant difference in terms of drainage volume of the abdominal drainage tubes in the 3day postoperative period, postoperative period to the drainage removal, the length of hospitalization, and postoperative complications between two groups (P>0.05). Postoperative levels of hemoglobin, albumin, and prealbumin were significant lower in TG group compared with those in PG group (P

    المصدر: Zhongguo linchuang yanjiu, Vol 37, Iss 2, Pp 201-205 (2024)

    وصف الملف: electronic resource

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المصدر: Cancer Urology; Том 19, № 4 (2023); 131-138 ; Онкоурология; Том 19, № 4 (2023); 131-138 ; 1996-1812 ; 1726-9776

    وصف الملف: application/pdf

    العلاقة: https://oncourology.abvpress.ru/oncur/article/view/1756/1501Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1756/1425Test; Combes A.D., Palma C.A., Calopedos R. et al. PSMA PET-CT in the diagnosis and staging of prostate cancer. Diagnostics (Basel) 2022;12(11):2594. DOI:10.3390/diagnostics12112594; García Garzón J.R., Arcocha Torres M., Delgado-Bolton R. et al. 68Ga-PSMA PET/CT in prostate cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed.) 2018;37(2):130–8. DOI:10.1016/j.remn.2017.07.004; Клинические рекомендации. Рак предстательной железы. 2021. Доступно по: https://oncology-association.ru/wp-content/uploads/2021/02/rpzh.pdfTest; NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer. Version 4.2023. Available at: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdfTest.; Fendler W.P., Eiber M., Beheshti M. et al. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging 2023;50(5):1466–86. DOI:10.1007/s00259-022-06089-w; Носов Д.А., Волкова М.И., Гладков О.А. и др. Практические рекомендации по лечению рака предстательной железы. Злокачественные опухоли: Практические рекомендации RUSSCO 2021;11(3s2):540–55. DOI:10.18027/2224-5057-2021-11-3s2-33; Malik D., Sood A., Mittal B.R. et al. Nonspecific uptake of 68Ga-prostate-specific membrane antigen in diseases other than prostate malignancy on positron emission tomography/computed tomography imaging: a pictorial assay and review of literature. Indian J Nucl Med 2018;33(4):317–25. DOI: 0.4103/ijnm.IJNM_81_18; Grünig H., Maurer A., Thali Y. et al. Focal unspecifc bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging. Eur J Nucl Med Mol Imaging 2021;48(13):4483–94. DOI:10.1007/s00259-021-05424-x; Vamadevan S., Shetty D., Le K. et al. Prostate-specific membrane antigen (PSMA) avid pancreatic neuroendocrine tumor. Clin Nucl Med 2016;41(10):804–6. DOI:10.1097/RLU.0000000000001308; Prabhu M., Damle N.A., Gupta R. et al. Demonstration of 68Ga-prostate-specific membrane Aantigen uptake in metastatic pancreatic neuroendocrine tumor. Indian J Nucl Med 2018;33(3):257–8. DOI:10.4103/ijnm.IJNM_6_18; Tremont-Lukats I.W., Bobustuc G., Lagos G.K. et al. Brain metastasis from prostate carcinoma: The M.D. Anderson Cancer Center experience. Cancer 2003;98(2):363–8. DOI:10.1002/cncr.11522; McCutcheon I.E., Eng K.Y., Logothetis C.J. Brain metastasis from prostate carcinoma: antemortem recognition and outcome after treatment. Cancer 1999;86(11):2301–11. DOI:10.1002/(sici)1097-0142(19991201)86:113.0.co;2-d; Salvati M., Frati A., Russo N. et al. Brain metastasis from prostate cancer: report of 13 cases and critical analysis of the literature. J Exp Clin Cancer Res 2005;24(2):203–7.; Barakat T., Agarwal A., McDonald R. et al. Solitary brain metastasis from prostate cancer: a case report. Ann Palliat Med 2016;5(3):227–32. DOI:10.21037/apm.2016.04.02; Rowe S.P., Pienta K.J., Pomper M.G., Gorin M.A. Proposal for a structured reporting system for prostate-specific membrane antigen-targeted PET imaging: PSMA-RADS Version 1.0. J Nucl Med 2018;59(3):479–85. DOI:10.2967/jnumed.117.195255; Werner R.A., Hartrampf P.E., Fendler W.P. et al. Prostate-specific Membrane Antigen Reporting and Data System Version 2.0. Eur Urol 2023;84(5):491–502. DOI:10.1016/j.eururo.2023.06.008; https://oncourology.abvpress.ru/oncur/article/view/1756Test

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية